Transcorneal oxygen therapy for glaucoma associated with sickle cell hyphema.
OBJECTIVE
To study three patients with glaucoma caused by sickle cell hyphema who were successfully treated with transcorneal oxygen therapy.


METHODS
Case reports. Three patients with increased intraocular pressure caused by sickle cell hyphema were administered transcorneal oxygen therapy using humidified oxygen at a flow rate that ranged from 1 to 3 l/minute.


RESULTS
All three patients had a dramatic reduction in their intraocular pressure within hours of receiving oxygen therapy. No complications were associated with the oxygen therapy.


CONCLUSIONS
Transcorneal oxygen therapy can reduce intraocular pressure in patients with glaucoma from sickle cell hyphema. Further study is warranted to evaluate this new therapy.
Benner
J D
JD
Delmarva Vitreoretinal Center, Salisbury, Maryland, USA. benner@shore.intercom.net
D000328:Adult; D002648:Child; D003315:Cornea; D005901:Glaucoma / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D006988:Hyphema / Q000150:complications*; D007429:Intraocular Pressure; D008297:Male; D010100:Oxygen / Q000627:therapeutic use*; D012805:Sickle Cell Trait / Q000150:complications*; D014792:Visual Acuity
D010100:Oxygen